#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 24

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Heart disease congenital

Not yet recruiting

Registered drugNo placebo

Safety and pharmacodynamics of cangrelor tetrasodium in paediatric patients with congenital heart disease undergoing percutaneous vascular procedures

Registered drugNo placebo

Germany

Participants:0–17 years
Substances:Cangrelor Tetrasodium

Contact Research Centre

Hormone-dependent prostate cancer+3

Not yet recruiting

InvestigationalNo placebo

BMS-986365 in Metastatic Castration-Sensitive Prostate Cancer in Patients with Suboptimal PSA Response After ADT and ARPI

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:BMS-986365

Contact Research Centre

Systemic scleroderma

Not yet recruiting

Registered drug

Lebrikizumab in Adults with Moderate to Severe Localized Scleroderma

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Lebrikizumab

Contact Research Centre

Acute lymphocytic leukaemia+1

Not yet recruiting

Registered drugNo placebo

A study to evaluate the safety and effectiveness of subcutaneous blinatumomab in adults and adolescents with relapsed, refractory, or minimal residual disease positive B-cell precursor acute lymphoblastic leukemia.

Registered drugNo placebo

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Blinatumomab

Contact Research Centre

Dry age-related macular degeneration

Not yet recruiting

Registered drug

A study to evaluate the safety and effectiveness of ADX-038 in adults with geographic atrophy caused by age-related macular degeneration.

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:ADX-038

Contact Research Centre

Glioblastoma

Not yet recruiting

Registered drugNo placebo

Phase 3 Randomized Study of Niraparib Tosilate Monohydrate vs. Temozolomide in Newly Diagnosed MGMT Unmethylated Glioblastoma

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Temozolomide

Contact Research Centre

Endocrine ophthalmopathy

Not yet recruiting

Investigational

A study testing teprotumumab compared to placebo in adult patients with moderate-to-severe active thyroid eye disease

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Teprotumumab

Contact Research Centre

Fallopian tube cancer+1

Not yet recruiting

Registered drugNo placebo

Study of TORL-1-23 and pegfilgrastim in women with advanced platinum-resistant ovarian, peritoneal, or fallopian tube cancer expressing CLDN6

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Glatiramer Acetate

Contact Research Centre

Medulloblastoma

Not yet recruiting

Registered drugNo placebo

Comparing two treatment regimens with drug combination for newly diagnosed low-risk medulloblastoma to evaluate cognitive function outcomes

Registered drugNo placebo

Germany

Participants:0–17 years
Substances:Carboplatin

Contact Research Centre

Enterobacter infection

Not yet recruiting

Registered drugNo placebo

Study on the Effectiveness of Intestifix, Colistin Sulfate, and Vancomycin for Patients with Infections from Multidrug-Resistant Enterobacteriaceae

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Colistin Sulfate

Contact Research Centre

Retinitis pigmentosa

Not yet recruiting

Investigational

Study on the Effectiveness and Safety of Ultevursen for Patients with Retinitis Pigmentosa Due to USH2A Gene Mutations

Investigational

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:ULTEVURSEN

Contact Research Centre

Non-small cell lung cancer

Not yet recruiting

InvestigationalNo placebo

Study on JDQ443 for First-Line Treatment in Patients with Advanced KRAS G12C-Mutated Non-Small Cell Lung Cancer

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:1-{6-[(4M)-4-(5-Chloro-6-Methyl-1H -Indazol-4-Yl)-5-Methyl-3-(1-Methyl-1H -Indazol-5-Yl)-1H -Pyrazol-1-Yl]-2-Azaspiro[3.3]Heptan-2-Yl}Prop-2-En-1-One

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.